CDK8 and neoplasm: Specific deletion of CDK8 in NK cells results in an enhancement of their anti-tumor responses (Witalisz-Siepracka et al., 2018), an activity that heavily relies on the action of different cytokines on natural killer (NK) cells (Hu et al., 2019).